- New System Utilizes RF Balloon Catheter Technology Designed to Deliver Therapy in Seconds Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology, ...

LAGUNA HILLS, Calif., Feb. 23, 2012 /PRNewswire/ -- Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology, announced today initial patient treatments ...

LAGUNA HILLS, Calif., May 1, 2012 /PRNewswire/ -- Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology for the treatment of hypertension, announced ...

LAGUNA HILLS, Calif. -- Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology for the treatment of hypertension, announced today that it would ...

Boston Scientific (NYSE:BSX) is jumping on the renal denervation bandwagon. The Natick, Massachusetts, medical device manufacturer announced Thursday that it is buying Caifornia startup Vessix ...

NATICK, Mass. (AP) -- Boston Scientific Corp. said Thursday it agreed to buy Vessix Vascular Inc., a company that makes system that uses radiotherapy to treat high blood pressure, in a deal worth as ...

is extending its reach into the strategically critical renal denervation market by signing a definitive agreement to acquire Vessix Vascular, Inc., a privately held company based in Laguna Hills, ...

NATICK, Mass., Nov. 8, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is extending its reach into the strategically critical renal denervation market by signing a definitive agreement ...

The presentation, titled “Percutaneous RF balloon-mediated renal denervation in under a minute: The V2 System by Vessix,” will be made by James R. Margolis, M.D., a luminary in the field of ...